Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Post-Traumatic Stress Disorders: HELP
Articles from Universita degli Studi di Brescia
Based on 3 articles published since 2010
||||

These are the 3 published articles about Stress Disorders, Post-Traumatic that originated from Universita degli Studi di Brescia during 2010-2020.
 
+ Citations + Abstracts
1 Article Rumination, posttraumatic stress disorder, and mood symptoms in borderline personality disorder. 2019

Dell'Osso, Liliana / Cremone, Ivan M / Carpita, Barbara / Dell'Oste, Valerio / Muti, Dario / Massimetti, Gabriele / Barlati, Stefano / Vita, Antonio / Fagiolini, Andrea / Carmassi, Claudia / Gesi, Camilla. ·Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. · Department of Mental Health , University of Siena, Siena, Italy. · Department of Molecular Medicine, University of Siena, Siena, Italy. ·Neuropsychiatr Dis Treat · Pubmed #31190829.

ABSTRACT:

2 Article Clinical efficacy of trauma-focused psychotherapies in treatment-resistant depression (TRD) in-patients: A randomized, controlled pilot-study. 2019

Minelli, Alessandra / Zampieri, Elisa / Sacco, Chiara / Bazzanella, Roberta / Mezzetti, Nicoletta / Tessari, Elisabetta / Barlati, Stefano / Bortolomasi, Marco. ·Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. Electronic address: alessandra.minelli@unibs.it. · Psychiatric Hospital "Villa Santa Chiara", Verona, Italy. · Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. · Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; Department of Mental Health and Addiction Services, ASST Spedali Civili, Brescia, Italy. ·Psychiatry Res · Pubmed #30711853.

ABSTRACT: In major depressive disorder (MDD) patients, life stress events represent a risk factor for a severe, early-onset, treatment-resistant and chronic endophenotype. Treatment-resistant depression (TRD) patients who have experienced traumatic events could benefit from evidence-based trauma-focused psychotherapies. Because this topic has never been investigated, the aim of this pilot trial was to evaluate whether trauma-focused cognitive-behavioural therapy (TF-CBT) and/or eye movement desensitization and reprocessing (EMDR) can help achieve depressive symptom remission in TRD patients. We carried out a single-blind randomized controlled trial with TRD patients and we compared EMDR (N = 12) with TF-CBT (N = 10). Patients received 3 individual sessions per week over a period of 8 weeks. The symptomatological assessments were performed at 4 timepoints: baseline (T0), 4 (T4), 8 (T8) and 12 (T12) weeks. After 24 weeks, a clinical interview was carried out by phone. All TRD patients showed a significant improvement in depressive symptomatology; however, post hoc comparisons showed a significant difference between the two treatment groups, with lower depressive symptom scores in the EMDR than in the TF-CBT group at the follow-up (T12). This effect was partly maintained at 24 weeks. This pilot study suggests that evidence-based trauma-focused psychotherapies, particularly EMDR, can represent effective interventions to treat TRD patients.

3 Article Childhood adversities and post-traumatic stress disorder: evidence for stress sensitisation in the World Mental Health Surveys. 2017

McLaughlin, Katie A / Koenen, Karestan C / Bromet, Evelyn J / Karam, Elie G / Liu, Howard / Petukhova, Maria / Ruscio, Ayelet Meron / Sampson, Nancy A / Stein, Dan J / Aguilar-Gaxiola, Sergio / Alonso, Jordi / Borges, Guilherme / Demyttenaere, Koen / Dinolova, Rumyana V / Ferry, Finola / Florescu, Silvia / de Girolamo, Giovanni / Gureje, Oye / Kawakami, Norito / Lee, Sing / Navarro-Mateu, Fernando / Piazza, Marina / Pennell, Beth-Ellen / Posada-Villa, José / Ten Have, Margreet / Viana, Maria Carmen / Kessler, Ronald C. ·Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Elie G. Karam, MD, Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Beirut and Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon; Howard Liu, SM, Maria Petukhova, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Ayelet Meron Ruscio, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Nancy A. Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Dan J. Stein, FRCPC, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Republic of South Africa; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, DrPH, IMIM-Hospital del Mar Research Institute, Pare de Salut Mar, Barcelona, Pompeu Fabra University (UPF), Barcelona and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Guilherme Borges, DrSc, Instituto Nacional de Psiquiatría, San Lorenzo Huipulco, Mexico; Koen Demytteraere, MD, PhD, Department of Psychiatry, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium; Rumyana V. Dinolova, MD, National Center of Public Health and Analyses, Sofia, Bulgaria; Finola Ferry, PhD, Bamford Centre for Mental Health and wellbeing, ulster University, Coleraine, UK; Silvia Florescu, MD, PhD, National School of Public Health, Management and Development, Bucharest, Romania; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, IRCCS-St. John of God Clinical Research Centre, Brescia, Italy; Oye Gureje, MD, PhD, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Sing Lee, MB, BS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Fernando Navarro-Mateu, MD, PhD, UDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud, Murcia, IMIB-Arrixaca, Murcia and CIBERESP-Murcia, Murcia, Spain; Marina Piazza, ScD, MPH, Universidad Cayetano Heredia; National Institute of Health, Lima, Peru; Beth-Ellen Pennell, MA, Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA; José Posada-Villa, MD, Faculty of Social Sciences Colegio Mayor de Cundinamarca University, Bogota, Colombia; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands; Maria Carmen viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo, Vitoria, Brazil; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA mclaughk@uw.edu. · Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Elie G. Karam, MD, Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Beirut and Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon; Howard Liu, SM, Maria Petukhova, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Ayelet Meron Ruscio, PhD, Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Nancy A. Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Dan J. Stein, FRCPC, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Republic of South Africa; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, DrPH, IMIM-Hospital del Mar Research Institute, Pare de Salut Mar, Barcelona, Pompeu Fabra University (UPF), Barcelona and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Guilherme Borges, DrSc, Instituto Nacional de Psiquiatría, San Lorenzo Huipulco, Mexico; Koen Demytteraere, MD, PhD, Department of Psychiatry, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium; Rumyana V. Dinolova, MD, National Center of Public Health and Analyses, Sofia, Bulgaria; Finola Ferry, PhD, Bamford Centre for Mental Health and wellbeing, ulster University, Coleraine, UK; Silvia Florescu, MD, PhD, National School of Public Health, Management and Development, Bucharest, Romania; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, IRCCS-St. John of God Clinical Research Centre, Brescia, Italy; Oye Gureje, MD, PhD, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Sing Lee, MB, BS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Fernando Navarro-Mateu, MD, PhD, UDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud, Murcia, IMIB-Arrixaca, Murcia and CIBERESP-Murcia, Murcia, Spain; Marina Piazza, ScD, MPH, Universidad Cayetano Heredia; National Institute of Health, Lima, Peru; Beth-Ellen Pennell, MA, Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA; José Posada-Villa, MD, Faculty of Social Sciences Colegio Mayor de Cundinamarca University, Bogota, Colombia; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands; Maria Carmen viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo, Vitoria, Brazil; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA. ·Br J Psychiatry · Pubmed #28935660.

ABSTRACT: